HROW Earnings & Financial Statements
Harrow Health, Inc.
$28.14
+$0.90(+3.30%)
35
Overall
20
Value
18
Tech
68
Quality
Market Cap
$1.02B
Volume
65.87K
52W Range
$27.00 - $54.85
Target Price
$63.00
HROW earnings and financial statements: Harrow Health, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
HROW Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $272.30M | $199.61M | $130.19M | $88.59M | $72.48M |
| Cost of revenue | $67.93M | $49.24M | $39.64M | $25.38M | $18.21M |
| Operating income | $30.52M | $8.82M | $431.0K | $1.92M | $1.61M |
| EBITDA | $45.77M | $23.30M | $14.05M | $5.58M | $4.26M |
| Net income | -$5.14M | -$17.48M | -$24.41M | -$14.09M | -$18.01M |
| EPS (diluted) | $-0.14 | $-0.49 | $-0.75 | $-0.51 | $-0.69 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $399.48M | $388.97M | $312.16M | $157.38M | $98.33M |
| Total liabilities | $347.39M | $319.67M | $241.75M | $130.14M | $87.40M |
| Shareholders’ equity | $52.45M | $69.65M | $70.77M | $27.59M | $11.29M |
| Cash and equivalents | $72.93M | $47.25M | $74.08M | $96.27M | - |
| Long-term debt | $251.09M | $228.33M | $192.41M | $111.51M | $77.68M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $43.86M | -$22.20M | $3.84M | $1.71M | $5.08M |
| Capital expenditure | -$887.0K | -$1.67M | -$152.55M | -$7.77M | -$28.51M |
| Free cash flow | $42.98M | -$23.88M | $2.36M | -$6.07M | -$23.43M |
| Dividends paid | - | - | - | - | $127.0K |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HROW | $28.14 | +3.3% | 65.87K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |